|
1
|
Image fusion analysis of 99m Tc-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy: the importance of the lacrimal gland.
|
Eur J Nucl Med Mol Imaging
|
2003
|
1.45
|
|
2
|
Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study.
|
BMC Endocr Disord
|
2008
|
1.41
|
|
3
|
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
|
J Nucl Med
|
2003
|
1.18
|
|
4
|
In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial.
|
Semin Nucl Med
|
2002
|
1.16
|
|
5
|
Bone scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
1.00
|
|
6
|
131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.99
|
|
7
|
131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.96
|
|
8
|
Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
|
Eur J Nucl Med Mol Imaging
|
2005
|
0.94
|
|
9
|
Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
|
Alcohol Clin Exp Res
|
2008
|
0.94
|
|
10
|
99mTc-N4-[Tyr3]Octreotate Versus 99mTc-EDDA/HYNIC-[Tyr3]Octreotide: an intrapatient comparison of two novel Technetium-99m labeled tracers for somatostatin receptor scintigraphy.
|
Cancer Biother Radiopharm
|
2004
|
0.93
|
|
11
|
67Ga scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.92
|
|
12
|
FDG-PET: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.92
|
|
13
|
Workshop report: clinical diagnosis and imaging of sacroiliitis, Innsbruck, Austria, October 9, 2003.
|
J Rheumatol
|
2004
|
0.91
|
|
14
|
Somatostatin receptor SPECT.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.91
|
|
15
|
Diagnostic accuracy of basal TSH determinations based on the intravenous TRH stimulation test: an evaluation of 2570 tests and comparison with the literature.
|
BMC Endocr Disord
|
2007
|
0.90
|
|
16
|
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.87
|
|
17
|
Breast scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.83
|
|
18
|
Gastric carcinoid type I tumour: new diagnostic and therapeutic method.
|
Eur J Gastroenterol Hepatol
|
2003
|
0.83
|
|
19
|
Reference values for thyrotropin.
|
Thyroid
|
2005
|
0.82
|
|
20
|
Multimodality cranial image fusion using external markers applied via a vacuum mouthpiece and a case report.
|
Strahlenther Onkol
|
2003
|
0.81
|
|
21
|
F-18 FDG PET for assessing tyrosine kinase-related signal transduction inhibition in a GIST c-kit-positive tumor patient by imatinib.
|
Clin Nucl Med
|
2005
|
0.81
|
|
22
|
Computed axial tomography-MIBI image fusion for preoperative localization in primary hyperparathyroidism.
|
Am J Surg
|
2004
|
0.80
|
|
23
|
Nutritional treatment of incipient thyroid autoimmune disease. Influence of selenium supplementation on thyroid function and morphology in children and young adults.
|
Clin Nutr
|
2005
|
0.80
|
|
24
|
99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.79
|
|
25
|
99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.78
|
|
26
|
Accuracy of preoperative pinhole subtraction single photon emission computed tomography for patients with primary and recurrent hyperparathyroidism in an endemic goiter area.
|
Surg Today
|
2004
|
0.78
|
|
27
|
Images in cardiovascular medicine. Generalized large vessel arteritis visualized by 18fluorodeoxyglucose-positron emission tomography.
|
Circulation
|
2003
|
0.77
|
|
28
|
Markers of bone resorption and formation during abstinence in male alcoholic patients.
|
Alcohol Clin Exp Res
|
2012
|
0.77
|
|
29
|
[99mTc]demotensin VI: biodistribution and initial clinical results in tumor patients of a pilot/phase I study.
|
Cancer Biother Radiopharm
|
2011
|
0.77
|
|
30
|
Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.76
|
|
31
|
Band leakage after laparoscopic adjustable gastric banding.
|
Obes Surg
|
2003
|
0.76
|
|
32
|
Inadequate description of an acupuncture treatment study for polycystic ovaries.
|
Fertil Steril
|
2012
|
0.75
|
|
33
|
The complexities of receptor binding.
|
Fertil Steril
|
2008
|
0.75
|
|
34
|
18F-FDG-positron emission tomography for diagnosis of large vessel arteritis in Behçet's disease.
|
Adv Exp Med Biol
|
2003
|
0.75
|
|
35
|
New perspectives of imaging techniques for diagnosis of organ manifestations in Behçet's disease.
|
Adv Exp Med Biol
|
2003
|
0.75
|
|
36
|
Somatostatin receptor scintigraphy using (99m)Tc-EDDA/HYNIC-TOC in graves' disease.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.75
|
|
37
|
Imaging of the corpus striatum without any activity at 192 MBq 18F-fluorodeoxyglucose PET after intoxication.
|
Eur J Nucl Med Mol Imaging
|
2005
|
0.75
|